Key result
Recurrence analysis for arrhythmia lacks standard thresholds and prospective validation in catheter ablation across 49 studies.
Its licence doesn't allow us to show a copy here.
Why the study?
Cardiac signals are nonlinear and non-stationary, limiting Fourier-based analysis for identifying catheter ablation substrates. Although recurrence quantification analysis and related recurrence methods make fewer assumptions, their use and methodological consistency in arrhythmia research had not been systematically synthesised.
Does recurrence quantification analysis improve substrate characterisation and guide catheter ablation in cardiac arrhythmias?
Systematic Review
Does recurrence quantification analysis improve substrate characterisation and guide catheter ablation in cardiac arrhythmias?
Recurrence quantification analysis captures nonlinear structure in fibrillatory cardiac signals distinct from dominant frequency, but methodological heterogeneity in threshold selection and a lack of prospective trials currently prevent its clinical translation for guiding catheter ablation.
Recurrence analysis should not yet guide arrhythmia care; leaves open need for standardized prospective validation trials.
Cardiac arrhythmias are a major cause of morbidity and mortality, and catheter ablation depends on accurate identification of the underlying substrate. Cardiac signals are nonlinear and non-stationary, which limits Fourier-based analysis. Recurrence quantification analysis (RQA) and related recurrence methods make fewer assumptions, but their use in arrhythmia research has not been systematically synthesised. This review examines what recurrence analysis has demonstrated, how consistently its methods have been applied, and what remains before it can support clinical substrate characterisation. Of 309 records retrieved from four databases (207 after deduplication), 48 studies met the eligibility criteria and citation searching added one, giving 49. Each study was examined in full text for its signals, cohorts, embedding parameters, threshold selection, metrics and results, and assigned to one of six methodological categories. The three studies that tested recurrence against surrogate or shuffled data each found structure in fibrillatory signals that matched stochastic surrogates did not reproduce. Recurrence metrics and dominant frequency were weakly correlated and diverged in substrate characterisation, so they are not interchangeable. Threshold selection was the most consequential uncontrolled variable: five strategies were in use, ten of the 35 studies that apply a threshold reported no selection rule, and only three examined how their results depended on it. Determinism and laminarity, although the most frequently reported metrics, were not consistently the strongest discriminators. Clinical readiness is not established: only one study used recurrence mapping prospectively to guide ablation, in ten patients without randomisation. A shared threshold-selection standard and prospective multicentre validation are needed.
No takes yet. Share an insight, caveat, or question.
Moualla et al. (2026) conducted a systematic review in Cardiac arrhythmias. Recurrence quantification analysis (RQA) and related recurrence methods vs. Dominant frequency / stochastic surrogates was evaluated on Methodological consistency, substrate characterisation, and clinical translation of recurrence analysis. Recurrence analysis across 49 arrhythmia studies lacked standardized thresholds (10/35 reported no rule) and was used prospectively to guide ablation in only 1 study (n=10).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: